Abstract 10139: Trends in Hospitalisations and Cardiac Transplants (CTs) Associated with Alcoholic Cardiomyopathy (ACM)
Abstract
Introduction: Alcoholic cardiomyopathy (ACM) constitutes a major indication for heart transplantation. Diagnostic delays are common due to its histopathological and clinical overlap with other forms of dilated cardiomyopathy. Objective: Given the limited literature on demographic determinants of ACM and associated cardiac transplants (CTs), this study aimed to evaluate national trends in ACM-related hospitalisations and CTs in the United States between 2016 and 2022. Methods: ACM-related hospitalisations and CT procedures were identified using ICD-10 diagnosis code 142.6 and relevant ICD-10 procedure codes within the National Inpatient Sample (NIS) database, with data weighted uniformly across the study period (2016-2022). Corresponding population estimates were derived from the U.S. Census Bureau. The study included patients of all ages, stratified into two cohorts: <40 years and ≥40 years. Statistical analyses were conducted using STATA version 17.0, and metrics including mean annual percentage change (MAPC), relative change (RC%), and 95% confidence intervals (CI) were calculated. Results: Analysing 147,455 ACM-related hospitalisations, we found a cohort primarily composed of males (85.88%), older adults (88.75%), and White individuals (61.94%). Cardiac transplants were performed in 165 patients, predominantly males (93.94%) and older adults (81.81%), with transplants occurring among White (45.54%), Black (21.21%), and Hispanic (21.21%) patients. Time trend analysis revealed a significant increase in hospitalisation rates among younger individuals (p = 0.001), notably higher in younger females (p = 0.004) and males (p = 0.001) Transplant rates increased for males and older adults, rising insignificantly for Whites (p = 0.069) and Hispanics (p = 0.507) but declining for Blacks (p = 0.069). Conclusion: From 2016 to 2022, hospitalisations for ACM rose significantly only among younger adults, driven by a 49% increase in women and a 43% increase in men under age 40, while rates in older patients, overall sexes, and most racial groups remained stable. In contrast, ACM-related cardiac transplant volume did not change in any demographic subgroup. These findings signal a growing disease burden in younger ACM patients and suggest that current transplant utilisation and referral practices may not be keeping pace. Focused prevention efforts in younger populations and a reappraisal of transplant candidacy pathways are warranted to address this emerging gap.